SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-045172
Filing Date
2021-02-16
Accepted
2021-02-16 17:07:14
Documents
1
Group Members
FLAGSHIP PIONEERING, INC.FLAGSHIP V VENTURESLABS RX FUND, L.P.FLAGSHIP VENTURELABS V MANAGER LLCFLAGSHIP VENTURES FUND V GENERAL PARTNER LLCFLAGSHIP VENTURESLABS V LLCNOUBAR B. AFEYAN, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G d53537dsc13g.htm SC 13G 151958
  Complete submission text file 0001193125-21-045172.txt   153874
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Subject) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91823 | Film No.: 21640640
SIC: 2836 Biological Products, (No Diagnostic Substances)